Table 2.
Correlation between miR-4738-3p expression and clinicopathological features in HCC tissues (n = 57, χ2-test).
| N | miR-4738-3p | Expression | P-value | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
| Age (year) | 0.258 | |||
| <60 | 45 | 20 (44.4%) | 25 (55.6%) | |
| ≥60 | 12 | 7 (58.3%) | 5 (41.7%) | |
| Gender | 0.261 | |||
| Male | 46 | 22 (47.8%) | 24 (52.2%) | |
| Female | 11 | 5 (45.5%) | 6 (54.5%) | |
| Tumor number | 0.132 | |||
| Single | 49 | 21 (42.9%) | 28 (57.1%) | |
| Multiple | 8 | 2 (25.0%) | 6 (75.0%) | |
| Tumor size | 0.022 | |||
| <5 cm | 27 | 10 (37.0%) | 17 (63.0%) | |
| ≥5 cm | 30 | 20 (66.7%) | 10 (33.3%) | |
| Tumor differentiation | 0.003 | |||
| I–II | 37 | 12 (32.4%) | 25 (67.6%) | |
| III–IV | 20 | 5 (25.0%) | 15 (75.0%) | |
| Tumor location | >0.05 | |||
| Left liver | 10 | 7 (30.0%) | 3 (70.0%) | |
| Right liver | 42 | 20 (47.6%) | 22 (52.4%) | |
| Whole liver | 5 | 2 (40.0%) | 3 (60.0%) | |
| Vascular invasion | >0.05 | |||
| Yes | 16 | 8 (50.0%) | 8 (50.0%) | |
| No | 41 | 19 (46.3%) | 22 (53.7%) | |
| Liver cirrhosis | 0.431 | |||
| Yes | 29 | 12 (58.6%) | 17 (41.4%) | |
| No | 28 | 13 (46.4%) | 15 (53.6%) | |
| Hepatitis virus | 0.408 | |||
| Yes | 6 | 2 (33.3%) | 4 (66.7%) | |
| No | 51 | 23 (45.1%) | 28 (54.9%) | |
| M stage | 0.017 | |||
| M0 | 46 | 18 (39.1%) | 28 (61.9%) | |
| M1 | 11 | 2 (18.2%) | 9 (81.8%) |